Overview

Early Intervention With Fluoxetine in Autism

Status:
Completed

Trial end date:
2008-02-01

Target enrollment:

Participant gender:

Summary

This study is a pilot study to evaluate the feasibility and safety of conducting a year long, double-blind, placebo-controlled trial of fluoxetine in pre-school children to enhance developmental processes in core areas impacted by autism.

Phase:

Phase 2

Details

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Fluoxetine